Skip to main content
. 2022 Aug 10;13:922264. doi: 10.3389/fendo.2022.922264

Table 4.

Univariate analysis for MACE.

Total Normal weight Overweight
HR (95% CI) P HR (95% CI) P HR (95% CI) P
Age 1.02 (0.98-1.06) 0.313 1.02 (0.95-1.10) 0.606 1.00 (0.96-1.05) 0.348
Male 2.18 (0.90-5.29) 0.084 3.11 (0.66-14.66) 0.152 1.54 (0.52-4.53) 0.725
Diabetes 2.68 (1.35-5.35) 0.005 4.48 (1.26-15.87) 0.020 2.79 (1.18-6.61) 0.019
SBP 1.00 (0.99-1.02) 0.803 0.99 (0.97-1.02) 0.617 1.00 (0.98-1.02) 0.714
DBP 1.00 (0.97-1.03) 0.831 0.97 (0.92-1.02) 0.270 1.00 (0.97-1.04) 0.900
TG 0.88 (0.61-1.27) 0.494 0.61 (0.17-2.24) 0.456 0.86 (0.58-1.29) 0.466
HbA1c 0.99 (0.75-1.30) 0.919 0.62 (0.39-1.74) 0.615 0.98 (0.72-1.32) 0.877
caIMR≥25 3.19 (1.52-6.71) 0.002 2.87 (0.81-10.19) 0.103 3.16 (1.24-8.01) 0.016

Univariate analysis enrolled factors with a P-value< 0.05 in the baseline. caIMR, coronary angiography−derived index of microcirculatory resistance; SBP, systolic blood pressure; DBP,diastolic blood pressure; TG, triglycerides; HbA1c, glycated hemoglobin; HR, hazard ratio; CI, confidence interval.